<DOC>
	<DOCNO>NCT01272999</DOCNO>
	<brief_summary>Prevnar ( 7 valent pneumococcal conjugate vaccine [ 7vPnC ] ) show effective ear infection child . Prevnar 13 new vaccine similar Prevnar . It expect effectiveness Prevnar 13 ear infection child similar observe following Prevnar . Pfizer committed conduct postmarketing study impact Prevnar 13 reduce ear infection among child .</brief_summary>
	<brief_title>Impact Prevnar 13 Ear Infections Children</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Mastoiditis</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Case eligibility base microbiologic data review document appropriately qualified member investigator 's study team case include study database . S pneumoniae identify middle ear fluid mastoiditis sample . Specimen obtain child age 18 year . As observational , laboratory base database study , exclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Acute otitis medium</keyword>
	<keyword>Prevnar 13</keyword>
	<keyword>Streptococcus pneumoniae</keyword>
</DOC>